Author

Miho Sato

RIKEN Center for Integrative Medical SciencesPrimary ORCID profile (0000-0001-9321-8487 · 2 papers)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Miho SatoiD2 papers · University of Zurich

Biology Disciplines

Click to filter author papers

Genetic & Genomic Medicine· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:ATAC-seq· 1 Research Focus:cell-cell communication· 1 Research Focus:differential expression· 1 Research Focus:gene regulatory network inference· 1 Organism:human· 1 Approach:statistical model· 1 Research Focus:variant effect prediction· 1

Frequent Co-Authors

Akari SuzukiiD· 1 shared Bunki NatsumotoiD· 1 shared Hajime InokuchiiD· 1 shared Haruka TakahashiiD· 1 shared Hiroaki HatanoiD· 1 shared Kazuhiko YamamotoiD· 1 shared Kazuyoshi IshigakiiD· 1 shared Kenichiro Asahara· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperGenetic & Genomic Medicine

Akari SuzukiORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Accurate, sensitive, and efficient chromatin accessibility quantification at target loci using UNIChro-seq.

Michihiro Kono, Hiroaki Hatano, Kenichiro Asahara, Masahiro Nakano, Reza Bagherzadeh, Tsugumi Kawashima, Takahiro Arakawa, Miho Sato, Hajime Inokuchi, Takahiro Nishino, Takahiro Itamiya, Haruka Takahashi, Bunki Natsumoto, Akari Suzuki, Kazuhiko Yamamoto, Kazuyoshi Ishigaki

The paper introduces UNIChro-seq, a method for quantifying chromatin accessibility at target loci, and demonstrates its application in analyzing disease risk alleles and genome-edited variants.

Nature Communications · Jul 20, 2026Peer-reviewedGenetic & Genomic Medicine